| Followers | 70 |
| Posts | 1643 |
| Boards Moderated | 1 |
| Alias Born | 01/27/2012 |
Sunday, March 18, 2012 2:07:55 PM
Thanks...And yes, I'm presenting that theory. Just the way things were playing out in 2011 that's the appearance to me. BD was in line to gain over 50% interest in Atrinsic if the Kazaa deal went through (That was at the O/S structure at the time of that deal)...The fact that ATRN inreased the O/S, delisted from NASDAQ and caused the dollar failure the deal to sell Kazaa to them wasn't as lucrative and thus BD pulled the deal off the table. I think Aaron Baker with his ROI white paper caught Kenshoo's interest so in May, Atrinsic sold promisary notes (Some to BD) with a conversion of over 2.00 per share and in June 11 Atrinsic BOD brought in a gun slinger (Goldfarb) to fight off the takeover so they could court Kenshoo for a buyout...See my post from the other night.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=73297263
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=73379493
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=73297263
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=73379493
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
